Derald H. Ruttenberg Treatment Center News
Issue # 2
Spring 2014
Welcome to the second installment of our e-newsletter for patients & friends of the Derald H. Ruttenberg Treatment Center. We hope you will enjoy these updates and look forward to giving you the latest news on happenings at our center.
Pet Assisted Therapy
Volunteer Susan Fraker with her dog, Grace, and Dr. Randall Holcombe
Pet Assisted Therapy is now available on select days in the Ruttenberg Center. Pet Assisted Therapy has been shown to:
  • Reduce stress and anxiety
  • Improve mood and energy level
  • Decrease perceived pain

If you are interested in receiving a visit from a certified therapy dog, please contact Stephanie Pelosi, LCSW at (212) 824-8762 or e-mail stephanie.pelosi@mountsinai.org.  

Pet Assisted Therapy visits are based on availability and medical clearance.

 

Post-Treatment Networking and Support Group for Cancer Survivors
 

Connect with other Cancer Survivors

Date: Monday, April 28th  

Time: 1 PM - 2 PM 

Location: Ruttenberg Treatment Center 3rd floor Resource Center

                 Hess Building,1470 Madison Avenue  

 

Advanced registration is appreciated but not required. Light refreshments will be served.   

Please contact Stephanie Pelosi, LCSW at (212) 824-8762 or stephanie.pelosi@mountsinai.org for more information, to register for this event, or to find out about future dates.  

In the News
The CBS "Sunday Morning" program aired a segment on February 16 called "How fruit flies may be key to the fight against cancer" featuring Mount Sinai's Ross Cagan, PhD and his genetic copy of a patient's tumor in a fruit fly. Watch the segment online at http://www.cbsnews.com/videos/are-fruit-flies-the-key-in-the-fight-against-cancer/.

Esquire magazine published an article entitled "Patient Zero" describing Mount Sinai's pioneering Personalized Cancer Therapy program with the story of patient Stephanie Lee. 
Clinical Trial Spotlight

This study will test the safety of a course of injections containing Poly-ICLC in patients with advanced solid tumors that can be easily and safely reached with a needle.  

 

Poly-ICLC is a compound that has been used to help the body in its fight against cancer.

 

Subjects may qualify if they have melanoma, non-melanoma skin cancer, head and neck cancer, sarcoma, or breast cancer.


For more information, click on the link above or call the Cancer Clinical Trials Office at 212-824-7309.
Metastasis Center Now Open
The Metastasis Center of The Tisch Cancer Institute specializes in serving the unique needs of patients with cancer that has spread to another area of the body beyond the initial site of the disease. With a personalized, concierge model of care, we offer access to advanced technologies and novel treatments individualized to achieve the best outcomes for each of our patients.

All Metastasis Center patients begin their care with a full-day visit to our Ruttenberg Treatment Center, where they will have a series of appointments coordinated to address their specific needs. This day-long visit ends with a conference in which the Center's team sits down to present treatment recommendations to the patient. Remote consultations are also available. To learn more, visit us online at mountsinai.org/metastasis or call 212-241-6756.

 

Project Miele
Artist Joan Di Lieto is a cancer survivor who believes in the healing
power of art.  Her series of paintings titled "Project Miele" is now a permanent installation recently added to the lobby of the Ruttenberg Center, where Di Lieto successfully received treatment.

The artwork, a series of triptychs, stem in part from the word "miele," Italian for "honey," which has been used as a medicinal aid for thousands of years.

For more information about "Project Miele," visit Joan Di Lieto's website.
Quick Links

Calendar of events
__________________________

What's New in Ruttenberg
  • Massage Therapy
  • Pet Assisted Therapy
  • Artist in Residence
  • Improved Wait Times
  • Chemistry Lab On Site
  • Survivor Support Group 

For more information on any of these, call 212-824-8791